FindTrial
Sign In

Randomized Controlled Trial to Evaluate Modified Radical Lymphadenectomy (D1+) for Gastric Cancer

Randomized Controlled Trial to Evaluate Modified Radical Lymphadenectomy (D1+) for Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000403
Enrollment
Unknown
Registered
2009-05-26
Start date
2009-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric carcinoma

Interventions

Group A:Radical Lymphadenectomy (D1)
Group B:Modified Radical Lymphadenectomy (D1+)

Sponsors

Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: Patients with potentially curable gastric adenocarcinoma that have been histologically proven.

Exclusion criteria

Exclusion criteria: Patients with 1. T4 carcinoma of the gastric; 2. Patients who suffer from gastric cancer with a distant organ metastasis, esophageal involvement, peritoneal dissemination or the classification of gastric cancer as Borrmann type IV; 3. With a history of previous or concomitant other cancer or gastrectomy for benign disease; 4. Accecpted chemotherapy or radiotherapy.

Design outcomes

Secondary

MeasureTime frame
recurrence-free survival, operative morbidity, hospital mortality, recurrence rate, operative time, qualiity of life, time of hospital stay;—

Primary

MeasureTime frame
overall survival;—

Countries

China

Contacts

Public ContactKehu Yang
nccgcg2009@126.com+86 0 13893117077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026